Largest Canadian Companies by Revenue — Health Care
Canadian companies ranked by trailing-twelve-month revenue on TSX and TSXV.
Updated November 11, 2026200 companiesTotal market cap $2414.3B
Showing 200 companies (CDRs hidden)
| Rank | Company | Symbol | Market Cap | P/E Ratio | Revenue (TTM) |
|---|---|---|---|---|---|
| 1 | Sanofi ADR | SNY:US | $112.7B | 23.4 | $51.0B |
| 2 | Amgen Inc | AMGN:US | $249.0B | 26.7 | $38.9B |
| 3 | Gilead Sciences Inc | GILD:US | $207.0B | - | $31.0B |
| 4 | Medline Inc. Class A Common Stock | MDLN:US | $53.6B | 92.5 | $30.7B |
| 5 | GE HealthCare Technologies Inc. | GEHC:US | $38.0B | 17.8 | $21.6B |
| 6 | Regeneron Pharmaceuticals Inc | REGN:US | $93.6B | 20.0 | $16.9B |
| 7 | BrightSpring Health Services, Inc. Common Stock | BTSG:US | $13.8B | 49.0 | $15.3B |
| 8 | Viatris Inc | VTRS:US | $22.8B | - | $14.7B |
| 9 | Henry Schein Inc | HSIC:US | $9.5B | 23.6 | $13.7B |
| 10 | Vertex Pharmaceuticals Inc | VRTX:US | $138.7B | 35.2 | $13.0B |
| 11 | Intuitive Surgical Inc | ISRG:US | $159.7B | 55.7 | $11.6B |
| 12 | Bausch Health Companies Inc | BHC:TO | $4.4B | - | $11.1B |
| 13 | Biogen Inc | BIIB:US | $37.7B | 107.5 | $10.3B |
| 14 | ICON PLC | ICLR:US | $15.3B | 81.9 | $8.2B |
| 15 | Medirom Healthcare Technologies Inc | MRM:US | $2M | 0.7 | $8.1B |
| 16 | Grifols SA ADR | GRFS:US | $5.7B | 10.2 | $7.6B |
| 17 | Agilent Technologies Inc | A:US | $43.3B | 29.7 | $7.4B |
| 18 | BeOne Medicines AG | ONC:US | $47.7B | 53.5 | $6.6B |
| 19 | Incyte Corporation | INCY:US | $24.8B | 62.2 | $6.0B |
| 20 | argenx NV ADR | ARGX:US | $58.3B | 32.1 | $5.9B |
| 21 | Option Care Health Inc | OPCH:US | $4.7B | 23.0 | $5.8B |
| 22 | The Ensign Group Inc | ENSG:US | $10.6B | 27.1 | $5.7B |
| 23 | Bausch + Lomb Corp | BLCO:TO | $10.1B | - | $5.4B |
| 24 | DexCom Inc | DXCM:US | $30.2B | 31.9 | $5.1B |
| 25 | Alnylam Pharmaceuticals Inc | ALNY:US | $20.9B | 7.9 | $5.0B |
| 26 | Alignment Healthcare LLC | ALHC:US | $1.5B | 52.4 | $4.9B |
| 27 | Jazz Pharmaceuticals PLC | JAZZ:US | $15.1B | 69.5 | $4.7B |
| 28 | IDEXX Laboratories Inc | IDXX:US | $55.7B | 47.6 | $4.7B |
| 29 | Illumina Inc | ILMN:US | $33.4B | 38.0 | $4.5B |
| 30 | Genmab AS | GMAB:US | $34.3B | 47.7 | $4.3B |
| 31 | The Cooper Companies, Inc | COO:US | $11.9B | 21.4 | $4.2B |
| 32 | Align Technology Inc | ALGN:US | $11.7B | 24.2 | $4.2B |
| 33 | Astrana Health Inc | ASTH:US | $1.7B | 31.9 | $3.9B |
| 34 | Neurocrine Biosciences Inc | NBIX:US | $17.1B | 24.4 | $3.7B |
| 35 | Biomarin Pharmaceutical Inc | BMRN:US | $10.9B | - | $3.7B |
| 36 | Dentsply Sirona Inc | XRAY:US | $1.9B | - | $3.6B |
| 37 | Bruker Corporation | BRKR:US | $9.4B | - | $3.5B |
| 38 | Adapthealth Corp | AHCO:US | $1.0B | - | $3.4B |
| 39 | Acadia Healthcare Company Inc | ACHC:US | $3.6B | - | $3.4B |
| 40 | Surgery Partners Inc | SGRY:US | $3.0B | - | $3.4B |
| 41 | MiniMed Group, Inc. Common Stock | MMED:US | $4.7B | - | $3.2B |
| 42 | Amneal Pharmaceuticals, Inc. Class A Common Stock | AMRX:US | $7.4B | 53.2 | $3.2B |
| 43 | Insulet Corporation | PODD:US | $10.4B | 23.9 | $3.2B |
| 44 | United Therapeutics Corporation | UTHR:US | $24.8B | 22.0 | $3.2B |
| 45 | Natera Inc | NTRA:US | $45.0B | - | $2.9B |
| 46 | Medpace Holdings Inc | MEDP:US | $18.3B | 36.3 | $2.8B |
| 47 | Clover Health Investments Corp | CLOV:US | $2.6B | 483.0 | $2.7B |
| 48 | Fortrea Holdings Inc. | FTRE:US | $2.1B | - | $2.7B |
| 49 | Royalty Pharma Plc | RPRX:US | $39.5B | 44.9 | $2.6B |
| 50 | Aveanna Healthcare Holdings Inc | AVAH:US | $2.9B | 10.5 | $2.6B |
| 51 | QuidelOrtho Corp | QDEL:US | $734M | - | $2.6B |
| 52 | Moderna Inc | MRNA:US | $108.8B | - | $2.5B |
| 53 | Exelixis Inc | EXEL:US | $17.5B | 21.5 | $2.5B |
| 54 | Privia Health Group Inc | PRVA:US | $3.1B | 93.9 | $2.4B |
| 55 | BioNTech SE | BNTX:US | $21.7B | - | $2.4B |
| 56 | RadNet Inc | RDNT:US | $6.2B | - | $2.4B |
| 57 | ICU Medical Inc | ICUI:US | $4.3B | 72.0 | $2.2B |
| 58 | Extendicare Inc | EXE:TO | $2.6B | 20.3 | $2.2B |
| 59 | Sarepta Therapeutics Inc | SRPT:US | $1.9B | 891.0 | $2.0B |
| 60 | Halozyme Therapeutics Inc | HALO:US | $11.7B | 25.9 | $1.8B |
| 61 | Alkermes Plc | ALKS:US | $7.8B | - | $1.8B |
| 62 | Lifestance Health Group Inc | LFST:US | $5.2B | 76.5 | $1.7B |
| 63 | Integra LifeSciences Holdings | IART:US | $1.0B | 78.9 | $1.7B |
| 64 | Merit Medical Systems Inc | MMSI:US | $5.2B | 32.7 | $1.6B |
| 65 | Lantheus Holdings Inc | LNTH:US | $6.6B | 25.0 | $1.6B |
| 66 | Phibro Animal Health Corporation | PAHC:US | $1.4B | 13.2 | $1.5B |
| 67 | Insmed Inc | INSM:US | $25.5B | - | $1.5B |
| 68 | WELL Health Technologies Corp | WELL:TO | $1.1B | 212.5 | $1.5B |
| 69 | Tempus AI, Inc. Class A Common Stock | TEM:US | $15.4B | - | $1.5B |
| 70 | LivaNova PLC | LIVN:US | $5.0B | 25.8 | $1.5B |
| 71 | P3 Health Partners Inc | PIII:US | $815M | - | $1.5B |
| 72 | Addus HomeCare Corporation | ADUS:US | $2.3B | 20.7 | $1.5B |
| 73 | Madrigal Pharmaceuticals Inc | MDGL:US | $9.3B | - | $1.4B |
| 74 | Supernus Pharmaceuticals, Inc. | SUPN:US | $1.6B | - | $1.4B |
| 75 | Indivior PLC Ordinary Shares | INDV:US | $4.3B | 10.2 | $1.4B |
| 76 | HealthEquity Inc | HQY:US | $8.6B | 37.4 | $1.4B |
| 77 | Progyny Inc | PGNY:US | $2.6B | 32.0 | $1.3B |
| 78 | Guardant Health Inc | GH:US | $21.5B | - | $1.3B |
| 79 | Legend Biotech Corp | LEGN:US | $4.6B | - | $1.3B |
| 80 | Waystar Holding Corp. Common Stock | WAY:US | $5.6B | 42.3 | $1.3B |
| 81 | Omnicell Inc | OMCL:US | $1.7B | 38.9 | $1.2B |
| 82 | Sotera Health Co | SHC:US | $4.6B | 26.7 | $1.2B |
| 83 | Bio-Techne Corp | TECH:US | $11.4B | 66.8 | $1.2B |
| 84 | ACADIA Pharmaceuticals Inc | ACAD:US | $3.7B | 10.0 | $1.2B |
| 85 | Pennant Group Inc | PNTG:US | $1.3B | 35.9 | $1.2B |
| 86 | PTC Therapeutics Inc | PTCT:US | $5.4B | - | $1.2B |
| 87 | Sienna Senior Living Inc | SIA:TO | $2.3B | 38.8 | $1.1B |
| 88 | Tandem Diabetes Care Inc | TNDM:US | $1.2B | - | $1.1B |
| 89 | Caris Life Sciences, Inc. Common Stock | CAI:US | $7.3B | 15.4 | $1.0B |
| 90 | Ascendis Pharma AS | ASND:US | $16.9B | 19.7 | $1.0B |
| 91 | Lumexa Imaging Holdings, Inc. Common Stock | LMRI:US | $1.3B | - | $1.0B |
| 92 | ANI Pharmaceuticals Inc | ANIP:US | $1.5B | 13.5 | $1.0B |
| 93 | Embecta Corp | EMBC:US | $351M | 4.2 | $1.0B |
| 94 | InnovAge Holding Corp | INNV:US | $1.3B | 153.5 | $1.0B |
| 95 | CorVel Corp | CRVL:US | $4.1B | 34.6 | $1.0B |
| 96 | Lakefront Biotherapeutics NV | LKFT:US | $2.2B | 3.2 | $991M |
| 97 | Harmony Biosciences Holdings | HRMY:US | $2.0B | 11.2 | $989M |
| 98 | Corcept Therapeutics Incorporated | CORT:US | $8.2B | 54.8 | $964M |
| 99 | Tilray Inc | TLRY:TO | $599M | - | $963M |
| 100 | Tilray Inc | TLRY:US | $421M | - | $963M |
| 101 | BioCryst Pharmaceuticals Inc | BCRX:US | $2.0B | - | $962M |
| 102 | Kiniksa Pharmaceuticals Ltd | KNSA:US | $7.8B | 74.8 | $946M |
| 103 | BridgeBio Pharma Inc | BBIO:US | $15.2B | - | $946M |
| 104 | SNDL Inc. | SNDL:US | $343M | - | $922M |
| 105 | Telix Pharmaceuticals Limited | TLX:US | $3.3B | 96.3 | $891M |
| 106 | Neogen Corporation | NEOG:US | $2.6B | - | $884M |
| 107 | Ionis Pharmaceuticals Inc | IONS:US | $6.6B | - | $874M |
| 108 | Axsome Therapeutics Inc | AXSM:US | $7.0B | - | $865M |
| 109 | Varex Imaging Corp | VREX:US | $783M | 34.8 | $865M |
| 110 | iRhythm Technologies Inc | IRTC:US | $3.0B | - | $854M |
| 111 | Alphatec Holdings Inc | ATEC:US | $1.1B | - | $840M |
| 112 | Orthofix Medical Inc | OFIX:US | $319M | - | $833M |
| 113 | Collegium Pharmaceutical Inc | COLL:US | $752M | 22.2 | $815M |
| 114 | Repligen Corporation | RGEN:US | $11.4B | - | $806M |
| 115 | Myriad Genetics Inc | MYGN:US | $567M | - | $804M |
| 116 | TG Therapeutics Inc | TGTX:US | $9.2B | 21.8 | $800M |
| 117 | Nutex Health Inc | NUTX:US | $1.2B | 7.8 | $797M |
| 118 | NeoGenomics Inc | NEO:US | $2.3B | - | $788M |
| 119 | Goodrx Holdings Inc | GDRX:US | $1.2B | 73.0 | $785M |
| 120 | Amphastar P | AMPH:US | $1.2B | 13.1 | $746M |
| 121 | Pacira BioSciences, Inc. | PCRX:US | $1.5B | 39.2 | $743M |
| 122 | Ultragenyx | RARE:US | $1.7B | - | $730M |
| 123 | TransMedics Group Inc | TMDX:US | $3.3B | 25.6 | $728M |
| 124 | Novocure Ltd | NVCR:US | $1.6B | - | $725M |
| 125 | Evotec SE ADR | EVO:US | $601M | - | $718M |
| 126 | Nurix Therapeutics Inc | NRIX:US | $1.8B | 6.6 | $702M |
| 127 | Tarsus Pharmaceuticals Inc | TARS:US | $3.4B | - | $682M |
| 128 | Mirum Pharmaceuticals Inc | MIRM:US | $6.1B | - | $671M |
| 129 | Arrowhead Pharmaceuticals Inc | ARWR:US | $6.9B | - | $669M |
| 130 | Opko Health Inc | OPK:US | $1.3B | - | $654M |
| 131 | Travere Therapeutics Inc | TVTX:US | $4.8B | - | $651M |
| 132 | UFP Technologies Inc | UFPT:US | $2.5B | 32.6 | $650M |
| 133 | Ascentage Pharma Group International | AAPG:US | $1.4B | - | $643M |
| 134 | 10X Genomics Inc | TXG:US | $8.6B | - | $619M |
| 135 | Azenta Inc | AZTA:US | $1.7B | - | $614M |
| 136 | AtriCure Inc | ATRC:US | $2.9B | 186.4 | $590M |
| 137 | Bioventus Inc | BVS:US | $727M | 13.1 | $586M |
| 138 | Veracyte Inc | VCYT:US | $2.1B | 16.8 | $582M |
| 139 | Sucro Limited | SUGR:V | $216M | 3.9 | $561M |
| 140 | Protagonist Therapeutics Inc | PTGX:US | $8.6B | 27.9 | $552M |
| 141 | HUTCHMED DRC | HCM:US | $2.6B | 151.6 | $549M |
| 142 | ADMA Biologics Inc | ADMA:US | $2.8B | 16.6 | $519M |
| 143 | Sinovac Biotech Ltd | SVA:US | $642M | 6.7 | $511M |
| 144 | Arcutis Biotherapeutics Inc | ARQT:US | $3.2B | 116.1 | $509M |
| 145 | Burning Rock Biotech Ltd | BNR:US | $131M | - | $501M |
| 146 | CareDx Inc | CDNA:US | $4.1B | 33.1 | $497M |
| 147 | Alvotech | ALVO:US | $1.7B | - | $495M |
| 148 | Krystal Biotech Inc | KRYS:US | $8.9B | 40.9 | $470M |
| 149 | Ardelyx Inc | ARDX:US | $724M | - | $468M |
| 150 | CorMedix Inc | CRMD:US | $415M | 2.6 | $462M |
| 151 | GeneDx Holdings Corp. | WGS:US | $2.0B | - | $454M |
| 152 | Liquidia Technologies Inc | LQDA:US | $4.3B | 34.4 | $451M |
| 153 | Zai Lab Ltd | ZLAB:US | $3.2B | - | $442M |
| 154 | Innoviva Inc | INVA:US | $1.4B | 8.1 | $438M |
| 155 | Twist Bioscience Corp | TWST:US | $9.0B | - | $432M |
| 156 | Immunocore Holdings Ltd | IMCR:US | $1.6B | - | $429M |
| 157 | Certara Inc | CERT:US | $1.8B | - | $426M |
| 158 | MannKind Corp | MNKD:US | $1.3B | - | $413M |
| 159 | Novavax Inc | NVAX:US | $1.8B | - | $412M |
| 160 | POMDOCTOR LIMITED American Depositary Shares | POM:US | $4M | - | $410M |
| 161 | Accuray Incorporated | ARAY:US | $11M | - | $402M |
| 162 | Ironwood Pharmaceuticals Inc | IRWD:US | $727M | 4.9 | $400M |
| 163 | MeiraGTx Holdings PLC | MGTX:US | $911M | 10.9 | $398M |
| 164 | BillionToOne, Inc. Class A Common Stock | BLLN:US | $5.5B | 124.9 | $397M |
| 165 | Pharming Group NV | PHAR:US | $870M | 38.4 | $387M |
| 166 | Iovance Biotherapeutics Inc | IOVA:US | $3.7B | - | $379M |
| 167 | Castle Biosciences Inc | CSTL:US | $1.1B | - | $377M |
| 168 | CareRx Corp | CRRX:TO | $197M | 7.6 | $377M |
| 169 | InMode Ltd | INMD:US | $777M | 11.2 | $375M |
| 170 | Xeris Pharmaceuticals Inc | XERS:US | $2.9B | - | $368M |
| 171 | Tactile Systems Technology Inc | TCMD:US | $583M | 25.3 | $356M |
| 172 | Inogen Inc | INGN:US | $160M | - | $355M |
| 173 | Procept Biorobotics Corp | PRCT:US | $1.2B | - | $352M |
| 174 | Organogenesis Holdings Inc | ORGO:US | $118M | - | $352M |
| 175 | Omada Health, Inc. Common Stock | OMDA:US | $936M | 37.7 | $333M |
| 176 | Amotiv Limited | AOV:TO | $577M | - | $332M |
| 177 | Fulgent Genetics Inc | FLGT:US | $663M | - | $330M |
| 178 | STAAR Surgical Company | STAA:US | $1.3B | 2521.0 | $328M |
| 179 | HealthStream Inc | HSTM:US | $884M | 41.3 | $328M |
| 180 | Evolus Inc | EOLS:US | $462M | - | $325M |
| 181 | AngioDynamics Inc | ANGO:US | $510M | - | $325M |
| 182 | Vericel Corp Ord | VCEL:US | $2.8B | 85.3 | $324M |
| 183 | Aurinia Pharmaceuticals Inc | AUPH:US | $2.2B | 7.2 | $322M |
| 184 | Aurora Cannabis Inc | ACB:US | $339M | - | $314M |
| 185 | Aurora Cannabis Inc | ACB:TO | $487M | - | $314M |
| 186 | Viemed Healthcare Inc | VMD:US | $339M | 23.6 | $310M |
| 187 | OrganiGram Holdings Inc | OGI:TO | $175M | 2.1 | $309M |
| 188 | OrganiGram Holdings Inc | OGI:US | $126M | 2.0 | $309M |
| 189 | Canopy Growth Corp | CGC:US | $280M | - | $308M |
| 190 | MiMedx Group Inc | MDXG:US | $483M | - | $304M |
| 191 | Vir Biotechnology Inc | VIR:US | $2.3B | - | $303M |
| 192 | Adaptive Biotechnologies Corp | ADPT:US | $4.5B | - | $298M |
| 193 | DocGo Inc | DCGO:US | $24M | - | $295M |
| 194 | Canopy Growth Corp | WEED:TO | $413M | - | $294M |
| 195 | Syndax Pharmaceuticals Inc | SNDX:US | $859M | - | $290M |
| 196 | Rigel Pharmaceuticals Inc | RIGL:US | $792M | 2.6 | $288M |
| 197 | Rhythm Pharmaceuticals Inc | RYTM:US | $7.8B | - | $281M |
| 198 | Kewaunee Scientific Corporation | KEQU:US | $98M | 12.1 | $277M |
| 199 | Harrow Health Inc | HROW:US | $1.0B | - | $276M |
| 200 | Arvinas Inc | ARVN:US | $443M | - | $275M |
Frequently Asked Questions
Which Canadian company ranks #1 by revenue (ttm) in Health Care?
As of November 11, 2026, Sanofi ADR (SNY:US) ranks #1 in Health Care at $51.0B.
How often is this ranking updated?
The table is rebuilt from live fundamentals throughout the day. This page currently shows data as of November 11, 2026.
How many companies are in this revenue (ttm) list?
This view shows 200 Canadian listings in Health Care. Canadian Depositary Receipts are hidden by default.
What is the difference between TSX and TSXV?
The Toronto Stock Exchange (TSX) lists larger established companies. The TSX Venture Exchange (TSXV) lists earlier-stage companies. Use the exchange filter to separate them.
Explore More Stock Rankings
Largest by Market Cap
Companies with the highest market capitalization
Highest Profit Margin
Most profitable companies by net margin
Highest Return on Equity
Companies generating the best returns for shareholders
Highest Return on Assets
Most efficient companies at using assets
Highest Dividend Yield
Top dividend-paying stocks
Fastest Revenue Growth
Companies with strongest year-over-year revenue growth
Fastest Earnings Growth
Companies with strongest year-over-year earnings growth